Literature DB >> 16359774

Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center.

Ingrid P M Gaugler-Senden1, Annemarie G Huijssoon, Willy Visser, Eric A P Steegers, Christianne J M de Groot.   

Abstract

OBJECTIVE: Preeclampsia, with an onset before 24 weeks' gestation is a rare but severe condition in pregnancy with little data of maternal and perinatal outcome, particularly after expectant management. We therefore, evaluated pregnancy outcome in these women at our department where temporising management was introduced as the standard policy in early onset preeclampsia. STUDY
DESIGN: We analysed retrospectively all consecutive women with preeclampsia, with an onset before 24 weeks' gestation, between 1 January 1993 and 31 December 2002 at a tertiary university referral center.
RESULTS: Twenty-six pregnancies, of which two were twin pregnancies, resulted in 65% of the women in at least one major maternal complication: maternal death (n=1), HELLP syndrome (n=16), eclampsia (n=5) and pulmonary edema (n=4). Thirty percent of these women presented already with serious morbidity at admission. The median prolongation of the pregnancy was 24 days (range 3-46 days). The overall perinatal mortality was 82%: 19 fetal deaths and 4 neonatal deaths.
CONCLUSION: Early onset preeclampsia, with an onset before 24 weeks' gestation, results in considerable maternal and perinatal morbidity and mortality. Therefore, expectant management should not be considered as a routine treatment option in these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16359774     DOI: 10.1016/j.ejogrb.2005.11.011

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  12 in total

1.  Maternal obesity and risk of infant death based on Florida birth records for 2004.

Authors:  Daniel R Thompson; Cheryl L Clark; Betsy Wood; Mary Beth Zeni
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

2.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

3.  First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Nandor Gabor Than; Offer Erez; Francesca Gotsch; Jimmy Espinoza; Samuel Edwin; Ilana Chefetz; Ricardo Gomez; Jyh Kae Nien; Marei Sammar; Beth Pineles; Sonia S Hassan; Hamutal Meiri; Yossi Tal; Ido Kuhnreich; Zoltan Papp; Howard S Cuckle
Journal:  Am J Obstet Gynecol       Date:  2008-06-09       Impact factor: 8.661

Review 4.  Pre-eclampsia: an update.

Authors:  Peter von Dadelszen; Laura A Magee
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

5.  Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia.

Authors:  Arrigo F G Cicero; Daniela Degli Esposti; Vincenzo Immordino; Martino Morbini; Cristina Baronio; Martina Rosticci; Claudio Borghi
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

6.  Birth outcomes of newborns after folic Acid supplementation in pregnant women with early and late pre-eclampsia: a population-based study.

Authors:  Ferenc Bánhidy; Abdallah Dakhlaoui; István Dudás; Andrew E Czeizel
Journal:  Adv Prev Med       Date:  2010-11-30

7.  Recurrent HELLP Syndrome at 22 Weeks of Gestation.

Authors:  Peter Kascak; Milos Paskala; Peter Antal; Radovan Gajdosik
Journal:  Case Rep Obstet Gynecol       Date:  2017-08-08

8.  Termination of pregnancy for maternal indications at the limits of fetal viability: a retrospective cohort study in the Dutch tertiary care centres.

Authors:  L van Eerden; G G Zeeman; G C M Page-Christiaens; F Vandenbussche; S G Oei; H C J Scheepers; J van Eyck; J M Middeldorp; E Pajkrt; J J Duvekot; C J M de Groot; A C Bolte
Journal:  BMJ Open       Date:  2014-06-17       Impact factor: 2.692

9.  Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population.

Authors:  Samieh Karimi; Majid Yavarian; Azadeh Azinfar; Minoo Rajaei; Maryam Azizi Kootenaee
Journal:  Iran J Reprod Med       Date:  2012-01

Review 10.  Acute Kidney Injury in Pregnancy-specific Disorders.

Authors:  J Prakash; V C Ganiger
Journal:  Indian J Nephrol       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.